Paxlovid in COVID-19 Vaccinated patients

Join us as we explore new trial data examing Paxlovid's effectiveness in high-risk, vaccinated patients. The GameChanger Significantly high risk patients are still at risk from active Covid-19 infection. A new trial looks at Paxlovid use in high-risk, vaccincated patients. Host Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health Reference New England Journal of Medicine Article Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode) CPE Information Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Discuss EPIC SR study findings. 2. Describe benefits of Paxlovid for specific patient groups based on trial data. 0.05 CEU/0.5 Hr UAN: 0107-0000-24-172-H01-P Initial release date: 05/13/2024 Expiration date: 05/13/2025 Additional CPE details can be found here. Follow CEimpact on Social Media: LinkedIn Instagram